Derms and Conditions

The Data Speaks for Itself: TYK2 Take 2 with Dr Andy Blauvelt


Listen Later

In this episode of Derms and Conditions, host James Q. Del Rosso, DO, is joined by Andy Blauvelt, MD, to explore the mechanism, efficacy, and safety of deucravacitinib, the first FDA-approved tyrosine kinase 2 (TYK2) inhibitor for psoriasis.

Dr Blauvelt begins by explaining how TYK2 inhibition differs from traditional JAK inhibition by targeting a more selective signaling pathway downstream of cytokine receptors. Unlike JAK1, JAK2, or JAK3, TYK2 is involved in a narrower range of cytokines, which may explain its distinct safety profile.

Dr Del Rosso and Dr Blauvelt also clarify why deucravacitinib lacks the boxed warning seen with other oral JAK inhibitors. With allosteric binding at the TYK2 pseudokinase domain, deucravacitinib avoids cross-inhibition of other JAKs, making it more selective and potentially safer. Long-term data now supports this distinction: 5-year safety results show no increased risk of major adverse cardiac events, malignancy, or serious infections, with only a small, manageable signal for herpesvirus infections.

The conversation turns to efficacy, which appears sustained over 5 years without antibody development, a potential advantage over biologics. Dr Blauvelt emphasizes its utility in high-impact areas such as the scalp, palms, soles, genitalia, and nails, and encourages systemic therapy even in patients with limited body surface area involvement when quality of life is severely affected.

Tune in to the full episode to learn how deucravacitinib fits into the current psoriasis treatment algorithm, what sets TYK2 inhibition apart from other oral options, and how real-world data is shaping clinical confidence in this novel therapy.

...more
View all episodesView all episodes
Download on the App Store

Derms and ConditionsBy Dermsquared

  • 4.9
  • 4.9
  • 4.9
  • 4.9
  • 4.9

4.9

47 ratings


More shows like Derms and Conditions

View all
The Daily by The New York Times

The Daily

111,156 Listeners

JAMA Dermatology Author Interviews by JAMA Network

JAMA Dermatology Author Interviews

17 Listeners

The Peter Attia Drive by Peter Attia, MD

The Peter Attia Drive

8,096 Listeners

Dermalogues by Canadian Dermatology Association

Dermalogues

14 Listeners

Learn Skin with Dr. Raja and Dr. Hadar by LearnSkin

Learn Skin with Dr. Raja and Dr. Hadar

35 Listeners

Life Kit by NPR

Life Kit

4,408 Listeners

Dermasphere - The Dermatology Podcast by Luke Johnson

Dermasphere - The Dermatology Podcast

136 Listeners

The PedsDocTalk Podcast: Child Health, Development & Parenting—From a Pediatrician Mom by Dr. Mona Amin

The PedsDocTalk Podcast: Child Health, Development & Parenting—From a Pediatrician Mom

1,473 Listeners

Cutaneous Miscellaneous: The Dermatology Residents Podcast by Dermsquared

Cutaneous Miscellaneous: The Dermatology Residents Podcast

6 Listeners

The Dr. Gabrielle Lyon Show by Dr. Gabrielle Lyon

The Dr. Gabrielle Lyon Show

1,192 Listeners

CME in Minutes: Education in Dermatology by Answers in CME

CME in Minutes: Education in Dermatology

3 Listeners

The Practical Dermatology Podcast by Practical Dermatology

The Practical Dermatology Podcast

0 Listeners

The Dermalorian Podcast by Dermatology Education Foundation

The Dermalorian Podcast

4 Listeners

Derms on Drugs by Scholars in Medicine

Derms on Drugs

30 Listeners

Skin Deep MDs with Dr. Mamina Turegano, Dr. Lindsey Zubritsky and Dr. Jenny Liu by Best in Wellness Media

Skin Deep MDs with Dr. Mamina Turegano, Dr. Lindsey Zubritsky and Dr. Jenny Liu

124 Listeners